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Interleukin-25 (IL-25 or IL-17E), a member of the
structurally related IL-17 family, functions as an
important mediator of T helper 2 cell-type (type 2)
responses. We examined the cell type-specific role
of IL-25-induced Act1-mediated signaling in protec-
tive immunity against helminth infection. Targeted
Act1 deficiency in epithelial cells resulted in amarked
delay in worm expulsion and abolished the expan-
sion of the Linc-Kit+ innate cell population in the
mesenteric lymph node, lung, and liver. Th2 cell-
inducing cytokine (IL-25 and IL-33) expression were
reduced in the intestinal epithelial cells from the
infected and IL-25-injected epithelial-specific Act1-
deficient mice. Adoptive transfer of Linc-Kit+ cells
or combined injection of IL-25 and IL-33 restored
the type 2 responses in these mice. Taken together,
these results suggest that epithelial-specific Act1
mediates the expansion of the Linc-Kit+ innate cell
population through the positive-feedback loop of
IL-25, initiating the type 2 immunity against helminth
infection.
INTRODUCTION
T helper 2 (Th2) cell-type cytokines play a critical role in protec-
tive immunity against parasitic helminth infections and also
mediate the pathogenesis of allergy and asthma (Paul and Zhu,
2010). An important question is how the initiation of Th2 cell-
type immune responses (type 2 responses) takes place in vivo.
Emerging studies have begun to reveal the mechanisms by
which the epithelium modulates type 2 responses through the
production of a group of epithelial-derived Th2 cell-driving
cytokines, including IL-25, IL-33, and TSLP (Artis, 2008; Holgate,
2007a; Kato and Schleimer, 2007; Saenz et al., 2008). These
epithelial-derived Th2 cell-driving cytokines maintain the
balance of host immune homeostasis and defense against
various pathogens (Anthony et al., 2007; Gregory et al., 2010;
Strickland et al., 2010).Homology-based cloning has revealed six IL-17 family
members, termed IL-17A to IL-17F. IL-17A (IL-17), a prototypic
member of IL-17 family, is required for host defense against
extracellular microorganisms and is involved in the pathogenesis
of various human and animal autoimmune diseases such as
rheumatoid arthritis, multiple sclerosis, and experimental auto-
immune encephalomyelitis (EAE) (Chang and Dong, 2011;
Iwakura et al., 2011). The most divergent member of the IL-17
family is IL-17E (IL-25); it is induced in airway epithelial cells in
response to allergens and expressed in mouse T lymphocytes
of the CD4+ subset with a Th2 cell profile and human innate
effector eosinophils and basophils (Fort et al., 2001; Zaph
et al., 2007). Transgenic expression as well as recombinant
IL-25 induce Th2 cell immunity and increase Th2 cell-type cyto-
kines IL-4, IL-5, IL-13, eosinophilia, and IgE (Angkasekwinai
et al., 2007; Strickland et al., 2010; Wang et al., 2007; Zaph
et al., 2008). Endogenous IL-25 has been shown to be critical
in allergen-induced pulmonary inflammation in a mouse asthma
model (Pan et al., 2001). Elevated IL-25 and IL-25R expression
were detected in asthmatic lung tissues, linking their roles in
allergic pulmonary inflammation (Fort et al., 2001). In IL-25-
deficient mice, expulsion of helminth parasites is delayed,
indicating the essential role of IL-25 signaling in protective immu-
nity against helminth infection (Fallon et al., 2006; Owyang et al.,
2006; Zhao et al., 2010).
IL-17 receptor (IL-17RAand IL-17RC) and IL-25R (IL-17RBand
IL-17RA) belong to a newly defined SEFIR protein family,
resulting from a conserved sequence segment called SEFIR in
their cytoplasmic domain (Novatchkova et al., 2003). Act1 is
a key component in IL-17 and IL-25 signaling (Claudio et al.,
2009; Novatchkova et al., 2003; Qian et al., 2007; Swaidani
et al., 2009). Act1 contains two TRAF binding sites (a helix-
loop-helix domain at the N terminus and a SEFIR domain at the
C terminus) and therefore Act1 is also a member of the SEFIR
protein family (Li, 2008). Upon IL-17 and IL-25 stimulation, Act1
is recruited to IL-17R and IL-25R through its SEFIR domain. We
recently found that Act1 also contains a U-box-like region and
has E3 ubiquitin ligase activity (Liu et al., 2009), which is critical
for its function. Mice deficient in Act1 have reduced allergen-
induced pulmonary eosinophilia. Furthermore, Act1 deficiency
in epithelial cells resulted in diminished type 2 responses and
less lung inflammation.Immunity 36, 821–833, May 25, 2012 ª2012 Elsevier Inc. 821
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IL-25-Act1 Axis Is Critical for Helminth ImmunityPrevious studies showed that CD4 mAb treatment attenuates
expulsion of N. brasiliensis, indicating the importance of CD4+
T cells in protective immunity against parasite infection (Day
et al., 1979; Katona et al., 1988). IL-25 alone can polarize naive
CD4+ T cells to Th2 cells (Wang et al., 2007) and augments
type 2 immune responses by enhancing the expansion and
function of TSLP-DC-activated Th2 memory cells (Angkasekwi-
nai et al., 2007). We found that Act1 deficiency in the T cell
compartment results in the abrogation of eosinophilic airway
infiltration as well as airway hyperresponsiveness (AHR) in
a mouse model of antigen-induced airway inflammation (Swai-
dani et al., 2011). Our findings suggest that Act1 expression in
T cells is required for cellular and humoral Th2 cell-mediated
allergic responses through its function in IL-25-induced develop-
ment of Th2 cells.
Several studies have also reported that IL-25 elicits an innate
immune cell population(s) by using helminth models, which is
capable of shaping Th2 cell immune responses and is required
for worm expulsion (Neill and McKenzie, 2011; Saenz et al.,
2010a). IL-25-induced innate effector cell populations (termed
either natural helper cells [NHCs], multipotent progenitor type 2
[MPPtype2] cells, nuocytes, or innate type 2 helper [Ih2] cells)
for type 2 immunity share similar features, all lacking expression
of lineage-defining markers with c-Kit expression (Fallon et al.,
2006;Moro et al., 2010; Neill et al., 2010; Price et al., 2010; Saenz
et al., 2010b). After exposure to helminth infections or allergens,
epithelial cells located at mucosal surfaces secrete IL-25 and
IL-33. IL-25 has been shown to induce the population expansion
of MPPtype2 cells, which can be differentiated into macrophages,
basophils, and mast cell populations. Whereas IL-25 and IL-33
have the capacity to expand IL-13- (and IL-5-) producing
nuocytes and Ih2 cells in vivo, NHCs have been shown to
produce IL-4, IL-5, and IL-13 after treatment with IL-33 and
IL-25. The functional commonality of MPPtype2 cells, nuocytes,
Ih2 cells, and NHCs is to promote CD4+ Th2 cell cytokine
responses and type 2 inflammation.
In this study, we used cell type-specific Act1 (a key adaptor for
IL-25 signaling)-deficient mice to examine how IL-25-mediated
signaling in different cellular compartments participates in
protective immunity against helminth infection through its impact
on the Linc-Kit+ innate immune cell population. Act1 deficiency
in macrophages or in T cells did not substantially impact worm
expulsion. However, targeted Act1 deficiency in epithelial cells
resulted in diminished Linc-Kit+ innate immune cell population
in the mesenteric lymph nodes (MLNs), reduced Th2 cell-type
cytokine expression, and a significant delay in worm expulsion.
Furthermore, the expression of IL-33 and IL-25 was reduced
in the intestinal epithelial cells (IECs) from the infected
epithelial-specific Act1-deficient mice compared to that in
wild-type control mice. These findings suggest that epithelial-
specific Act1 is critical for IL-25-dependent expansion of
the Linc-Kit+ innate cell population probably through the ampli-
fication of Th2 cell-driving cytokines (IL-33 and IL-25) and
consequent helminth expulsion. This study provides an impor-
tant cellular and molecular mechanism for how the initiation
of type 2 immune responses takes place in vivo. Specifically,
we elucidate how epithelial-specific Act1 mediates IL-25-
dependent helminth expulsion through the positive-feedback
loop of IL-25.822 Immunity 36, 821–833, May 25, 2012 ª2012 Elsevier Inc.RESULTS
Act1 Deficiency Attenuated the Initiation of Type 2
Responses and Delayed Worm Expulsion
To determine the role of IL-25-induced Act1-mediated signaling
in protective immunity against gastrointestinal helminth para-
sites, wild-type (WT) and Act1-deficient (Act1/) mice were
infected with N. brasiliensis larvae and sacrificed 5, 10, and
15 days after infection. The infected mice were monitored for
worm burden and type 2 responses. As shown in Figure 1A,
the WT and Act1/ mice showed similar worm burdens at day
5 after infection, but the WT mice displayed reduced worm
burden compared to theAct1/mice by day 10 and day 15 after
infection. However, worm burdens eventually went down in
Act1/ mice 20 days after infection, suggesting that Act1
deficiency did not completely abolish type 2 immunity, but rather
delayed it. We next assessed Th2 cell-type cytokine production
from themesenteric lymph nodes of the infectedWT andAct1/
mice. TheWT and Act1/mesenteric lymph node cells from the
infected mice were restimulated with CD3 and CD28 antibodies,
followed by measurement for Th2 cell-type cytokines. Although
similar amounts of IL-4 and IL-13 were detected in the WT and
Act1/mice at day 5 after infection, the Act1/mice produced
substantially less IL-4 and IL-13 than did the WT mice by day 10
after infection (Figures 1B and 1C). Interestingly, the production
of IL-4 and IL-13 was actually increased in Act1/ mice by day
15 after infection (Figures 1B and 1C), probably as a result of the
persistent higher worm burden in the Act1/mice compared to
the WT mice. These data suggest that Act1 deficiency attenu-
ated the initiation of type 2 responses, resulting in delayed
worm expulsion. In support of this, we noted that the IgE concen-
trations in the serum peaked at a much later time in Act1/mice
(day 15) as compared to that in WT mice (day 10) in response to
infection (Figure 1D). Because Th2 cell-type cytokines are known
to mediate lung inflammation during N. brasiliensis infection, we
analyzed inflammatory cell infiltration in the bronchoalveolar
lavage (BAL) in infected WT and Act1/ mice. There was
more leukocyte infiltration in BAL of the WT mice than that in
Act1/ mice, including macrophages, granulocytes, and
T cells (Figures 1E and 1F). Furthermore, the Th2 cell-associated
gene expression (Il4, Il5, Il13,Ccl11, Il25, and Tslp) was substan-
tially reduced in the lung tissues of the infected Act1/ mice
compared to that in WT mice (Figure S1A available online).
Previous studies have shown that infection with N. brasiliensis
induces a population of Linc-Kit+ cells that is required for
worm expulsion. We analyzed this population in the mesenteric
lymph nodes of WT and Act1/ mice 5 days after infection.
The frequency and absolute number of Linc-Kit+ cells were
dramatically increased in wild-type mice (about 30-fold) but
not in Act1/ mice (Figure 1G). Consistent with the literature,
this Linc-Kit+ innate effector cell population expresses IL-5
and IL-13 (Figure S1B) and a unique set of cell surface markers
(including IL-25R, IL-33R [T1/ST2], IL-9R, and ITGA4) (Figure 1H).
In addition, we also detected expression of certain chemokine
receptors such as CCR4 and CCR8 in these Linc-Kit+
innate effector cells, which might play an important role in the
chemotaxis of this cell population during infection (Figure 1H).
The expression of the cell surface markers and several important
transcription factors (GATA3, STAT6, and JunB) for Th2 cell-type
Figure 1. Act1 Deficiency Resulted in
Reduced Type 2 Responses and Delayed
Worm Expulsion
(A) Act1/ and Act1+/+ mice were sacrificed 5, 10,
and 15 days after infection, followed by analysis of
worm burden in intestine of each mouse.
(B and C) Mesenteric lymph nodes were taken
from the infected mice at indicated time points.
Cells were restimulated by anti-CD3 and anti-
CD28 overnight, followed by IL-4 and IL-13 ELISA
in the collected supernatants.
(D) Serum IgE levels were assayed by ELISA.
(E and F) Different cell subsets in BAL of Act1-
deficient and wild-type control mice were
analyzed by flow cytometry 5 days after infection.
Total cell numbers and absolute number of each
subset were shown.
(G) Act1-deficient and wild-type control mice were
sacrificed 5 days after infection and mesenteric
lymph nodes were collected. Plots shown are
gated on live, lineage-negative cells (CD3ε, CD4,
CD8, TCR-b, TCR-gd, B220, CD19, NK1.1,
Ter119, Gr-1, CD11b, and CD11c). The frequency
of Linc-Kit+ cells (left) and absolute numbers
(right) were shown. All the data represent mean
(n = 4) ± SEM; *p < 0.05, **p < 0.01.
(H) Linc-Kit+ cells were sorted by MACS and
FACS, then sorted cells were restimulated by
IL-25 or IL-33. Th0 helper T cells and unrest-
imulated Linc-Kit+ cells were included as
controls. Specific gene expression was shown as
mean (n = 4) ± SEM. The experiment was repeated
three times.
See also Figures S1 and S2.
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IL-25-Act1 Axis Is Critical for Helminth Immunitycytokine gene expression were increased upon IL-25 and IL-33
stimulation (Figure 1H). Taken together, Act1 deficiency resulted
in reduced expansion of the innate effector cell population,
attenuated type 2 responses, and delayed worm expulsion.
Act1 is a key component in IL-17 and IL-25 signaling. Whereas
Act1 is required for IL-17-dependent signaling and autoimmune
inflammatory disease (Qian et al., 2007), Act1 deficiency
abolishes IL-25-induced expression of Th2 cell-type cytokines
and pulmonary eosinophilia (Claudio et al., 2009; Swaidani
et al., 2009). Although expulsion of helminth parasites is delayed
in Il25/ mice (Fallon et al., 2006; Owyang et al., 2006), it
remains unclear whether IL-17 signaling has any impact on the
protective immunity against helminth infection. IL-17 signalsImmunity 36, 821–through a heteromeric receptor complex,
consisting of IL-17RA and IL-17RC
(Gaffen, 2009; Ho and Gaffen, 2010; Toy
et al., 2006; Trajkovic et al., 2001). To
determine the impact of IL-17 signaling
on worm expulsion, wild-type Il17a/
mice were infected with N. brasiliensis
larvae and sacrificed 10 and 15 days after
infection. IL-17A deficiency did not have
substantial impact on worm burden and
type 2 responses (Figure S2). These
results indicate that IL-17 signaling is
dispensable for N. brasiliensis expulsion.
The impact of Act1 deficiency on wormexpulsion is probably due to the disruption of IL-25 signaling
during infection.
Macrophage- and T Cell-Specific Act1 Are Dispensable
for Helminth Expulsion
Although IL-25 signaling has been shown to play a critical role in
worm expulsion, it remains unclear what specific cell types
directly participate in the IL-25-Act1-mediated protective
immunity. Macrophages are innate immune cells with well-
established roles not only in the primary response to pathogens
but also in tissue homeostasis, coordination of the adaptive
immune response, inflammation, resolution, and repair (Martinez
et al., 2009). Macrophages, known for their association with833, May 25, 2012 ª2012 Elsevier Inc. 823
Figure 2. Macrophage Act1 Is Dispensable for Worm Expulsion
(A) Bonemarrowmacrophages fromAct1/ andAct1+/+micewere untreated or treatedwith IL-25 (100 ng/ml), IL-4 (10 ng/ml), or IL-25+IL-4 for 24 hr, followed by
analysis of gene expression by real-time PCR.
(B) CD11bCreAct1fl/mice and CD11bCreAct1fl/+ were sacrificed 10 and 15 days after infection, followed by analysis of worm burden in intestine of each mouse.
(C and D) Mesenteric lymph nodes were taken from the infected mice at indicated time points. Cells were restimulated by anti-CD3 and anti-CD28 for overnight,
followed by IL-4 and IL-13 ELISA in the collected supernatants.
(E) Serum IgE levels were measured by ELISA.
Data represent mean (n = 4) ± SEM; *p < 0.05. The experiment was repeated three times. See also Figure S4.
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IL-25-Act1 Axis Is Critical for Helminth ImmunityIFN-g-dominant Th1 cell-type responses to infections of bacteria
and viruses, also play an essential role in the type 2 inflammatory
response to helminthes (Kreider et al., 2007). These macro-
phages have been classified as alternatively activated macro-
phages (AAMFs) because they express a specific set of
signature genes including RELMa, Ym1, and Arginase1. Rapid
increases of AAMFs are observed in the lung by 4 days after
N. brasiliensis infection, and this increase is associated with
elevated RELMa, Ym1, and Arginase1 (Siracusa et al., 2008).
One important question is whether IL-25 can augment alterna-
tive macrophage activation. To test this, we treated bone-
marrow-derived macrophages (BMDMs) with IL-25, IL-4, or
IL-25+IL-4 for 24 hr, followed by analysis of the signature genes
associated with alternatively activated macrophages (AAMFs).
Although IL-25 stimulation alone did not induce the expression
of Arginase1, Ym1, and RELMa, IL-25 had a synergistic effect
on IL-4-induced Arginase1 expression. IL-25 alone upregulated
the expression of IL-13 and MCP-1 in BMDMs and also syner-
gized with IL-4 to further induce the expression of IL-13, MCP-1,
and CCL-17 (Figure 2A). Importantly, the IL-25-mediated impact
on gene expression in BMDMs was Act1 dependent.
We then tested whether deletion of Act1 in macrophages
would have an effect on worm expulsion in vivo. CD11bCre824 Immunity 36, 821–833, May 25, 2012 ª2012 Elsevier Inc.transgenic mice (generated with the promoter for CD11b, an
integrin expressed exclusively in the myeloid lineage) express
Cre in macrophages and also in other myeloid cells such as
neutrophils. CD11bCreAct1+/ mice were bred onto Act1fl/fl to
generate control mice (CD11bCreAct1fl/+) and myeloid-specific
Act1-deficient mice (CD11bCreAct1fl/). The deletion of Act1 in
macrophages has been confirmed (Kang et al., 2010).
CD11bCreAct1fl/mice and littermate control CD11bCreAct1fl/+
mice were infected by N. brasiliensis and sacrificed 10 and
15 days after infection. Myeloid-specific Act1 deficiency did
not have substantial impact on worm burden and type 2
responses (Figures 2B–2E). Furthermore, we also analyzed the
Linc-Kit+ cell population in the mesenteric lymph nodes of
control mice (CD11bCreAct1fl/+) and macrophage-specific
Act1-deficient mice (CD11bCreAct1fl/) 5 days after infection.
The frequency and absolute number of Linc-Kit+ cells were
induced to similar levels in these two groups of mice (data not
shown). Taken together, these results clearly indicate that that
IL-25-induced Act1-mediated signaling in macrophages is
dispensable for N. brasiliensis expulsion.
Expulsion of N. brasiliensis is a T cell-dependent process
(Voehringer et al., 2006). We recently found that Act1 deficiency
in the T cell compartment results in the abrogation of eosinophilic
Figure 3. Epithelial Cell-Specific Act1 Is
Critical for Type 2-Dependent Worm Expul-
sion
(A) Epithelial-specific Act1-deficient and littermate
control mice were sacrificed 10 and 15 days after
infection, followed by analysis of worm burden in
intestine of each mouse.
(B and C) The expression of IL-4, IL-5, and IL-13 in
the lung and mesenteric lymph nodes after infec-
tion were analyzed by real-time PCR.
(D) Serum IgE concentrations were measured by
ELISA.
(E) BAL infiltration.
Data represent mean (n = 4) ± SEM; *p < 0.05. The
experiment was repeated three times.
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IL-25-Act1 Axis Is Critical for Helminth Immunityairway infiltration as well as airway hyperresponsiveness (AHR)
in a mouse model of antigen-induced airway inflammation
(Swaidani et al., 2011). Our findings suggested that Act1 expres-
sion in T cells is required for cellular and humoral Th2 cell-medi-
ated allergic responses through its function in IL-25-induced
development of Th2 cells. Therefore, it is important to determine
whether T cell-specific Act1 is also critical for helminth expul-
sion. LckCre transgenic mice express Cre in T cell progenitor
cells. LckCreAct1+/ mice were bred onto Act1fl/fl mice to
generate control mice (LckCreAct1fl/+) and T cell-specific
Act1-deficient mice (LckCreAct1fl/). LckCreAct1fl/ mice and
littermate control LckCreAct1fl/+ mice were infected by
N. brasiliensis. T cell-specific Act1 deficiency did not have
substantial impact on worm burden and type 2 responses (Fig-
ure S4 and data not shown). Consistently, the Linc-Kit+ cell
population in the MLNs were induced to similar numbersImmunity 36, 821–5 days after infection in control mice
(LckCreAct1fl/+) and T cell-specific Act1-
deficient mice (LckCreAct1fl/) (data not
shown). These results clearly indicate
that IL-25-induced Act1-mediated sig-
naling in T cells is dispensable for
N. brasiliensis expulsion.
Epithelial Cell-Specific Act1 Is
Critical for IL-25-Dependent
Helminth Expulsion
Previous studies suggest that epithelial
cells play an important role in pro-
tective immunity against gastrointestinal
helminth parasites (Herbert et al., 2009;
Zaph et al., 2007). Epithelial cells are
a major source of IL-25, promoting
Th2 cytokine responses at mucosal
sites. One important observation from
our previous study was that Act1
deletion in the epithelial compartment
resulted in attenuation of pulmonary
inflammation after the induction of an
antigen-induced murine asthma model.
These results suggested that epithelial
cells produce IL-25 and also respond to
IL-25. Therefore, we examined whetherthe epithelial-specific Act1 is also critical for worm expulsion.
K18Cre transgenic mice express Cre in epithelial cells.
K18CreAct1+/ mice were bred onto Act1fl/fl mice to generate
control mice (K18CreAct1fl/+) and epithelial-specific Act1-defi-
cient mice (K18CreAct1fl/). K18CreAct1fl/ mice and littermate
control K18CreAct1fl/+ mice were infected by N. brasiliensis
and sacrificed 5, 10, and 15 days after infection. Importantly,
we observed that epithelial-specific Act1-deficient mice dis-
played very similar phenotype as the complete Act1-deficient
mice in response to infection. Worm expulsion was substantially
delayed in K18CreAct1fl/mice compared to the K18CreAct1fl/+
control mice (Figure 3A). It should be noted that whereas
worm burdens were greatly reduced in control mice 10 days
after infection, worms were expelled in epithelial-specific
Act1-deficient mice 20 days after infection (Figure 3A and data
not shown). Consistent with the worm burden results, the833, May 25, 2012 ª2012 Elsevier Inc. 825
Figure 4. Act1-Mediated Signaling in Epithelium Is Required for the IL-25-Induced Expansion of Lin–c-Kit+ Cells
(A) Frequencies of Linc-Kit+ cells in the mesenteric lymph nodes of K18CreAct1fl/ and K18CreAct1fl/+ mice after 4 days of PBS or IL-25 treatment by i.p. or
5 days after worm infection. Plots shown are gated on lineage-negative cells.
(B and C) Total cell numbers (B) or Linc-Kit+ cell numbers (C) in mesenteric lymph nodes from K18CreAct1fl/ and K18CreAct1fl/+ mice after 4 days of PBS or
IL-25 treatment by i.p. or 5 days after worm infection.
(D) Number of total MLN cells or of T cells (CD4+ or CD8+), B cells (CD19+), dendritic cells (CD11c+), and mast cells from K18CreAct1fl/ and K18CreAct1fl/+ mice
5 days after worm infection.
(E) Absolute number of MLN IL-13+ cells 5 or 10 days after infection.
(F and G) Absolute number of Linc-Kit+ cells in the lung (F) and liver (G).
(H) Gene expression of MLN Linc-Kit+ cells fromK18CreAct1fl/ and K18CreAct1fl/+mice 5 days after worm infection. Isolated cells were restimulated with IL-25,
and cells without restimulation were included as controls.
Data represent mean (n = 4) ± SEM; *p < 0.05, **p < 0.01. The experiment was repeated two times. See also Figure S3.
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IL-25-Act1 Axis Is Critical for Helminth Immunityserum IgE levels and the Th2 cytokines (IL-4, IL-5, and IL-13)
in MLNs and in the lung tissues peaked at much later time
in the epithelial-specific Act1-deficient mice (day 15) as
compared to that in the K18CreAct1fl/+ mice (day 10) (Figures
3B–3D). Leukocyte infiltration (especially eosinophils) in BAL
was significantly decreased in the Act1-deficient mice 5 days
after infection compared to that in wild-type mice (Figure 3E).
Taken together, these data demonstrated that epithelial-specific
Act1 signaling is critical for type 2 responses and worm
expulsion.826 Immunity 36, 821–833, May 25, 2012 ª2012 Elsevier Inc.Act1-Mediated Signaling in Epithelium Is Required
for the IL-25-Induced Expansion of Lin–c-Kit+ Cells
Because our results indicate that epithelial-specific Act1 is
necessary for worm expulsion and type 2 responses, we hypoth-
esized that IL-25 signaling in epithelium mediates the expansion
of the Linc-Kit+ cell population that promotes Th2 cell
responses. To test this hypothesis, we examined the Linc-Kit+
cell population in MLNs of the IL-25-injected or worm-
infected epithelial-specific Act1-deficient (K18CreAct1fl/) and
control wild-type (K18CreAct1fl/+) mice (Figures 4A and 4B).
Figure 5. IL-25-Induced Type 2 Cytokines
and Chemokines in Epithelial Cells
(A) Infected K18CreAct1fl/ and K18CreAct1fl/+
mice were sacrificed 10 days after infection. Gene
expressions in intestinal epithelial cells after
infection were analyzed by real-time PCR.
(B) Epithelial-specific Act1-deficient and littermate
control mice were subjected to intraperitoneal
injection of IL-25 (2 mg/mouse, every 24 hr for
2 days), followed by analysis of gene expression in
intestinal epithelial cells by real-time PCR.
Data represent mean (n = 4) ± SEM; *p < 0.05. The
experiment was repeated two times.
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IL-25-Act1 Axis Is Critical for Helminth ImmunityIL-25-induced expansion of the Linc-Kit+ cell population in
MLNswasmuch reduced in the epithelial-specific Act1-deficient
(K18CreAct1fl/) mice as compared to that in wild-type
(K18CreAct1fl/+) mice. Similar results were obtained with
worm-infected K18CreAct1fl/ and K18CreAct1fl/+ mice (Figures
4A and 4B). In addition, the total cell number ofMLN cells and the
absolute number of T cells, B cells, macrophages, andmast cells
were also moderately increased in both IL-25-treated and in-
fected wild-type mice compared with that in epithelial Act1-defi-
cient mice (Figures 4C–4E and data not shown). However, the
Linc-Kit+ cell population expanded the most after IL-25 treat-
ment and worm infection. Although about 70% of the Linc-Kit+
cells were IL-13 positive, less than 5% of the CD4+ T cells were
IL-13-producing cells in MLNs 5 days after infection (data not
shown). Act1 deficiency in epithelium greatly diminished the
Linc-Kit+ cells but not CD4+ Th2 cell population 5 days after
infection (Figure 4E). The IL-13-producing MLN CD4+ Th2 cell
population was expanded 10 days after infection, which was
only partially dependent on the epithelial-specific Act1.
Previous studies have shown that Linc-Kit+ cells can be
induced systemically after worm infection (Price et al., 2010).
Because K18 promoter allows expression of Cre in epithelium
of all internal organs (including lung and liver), the
K18CreAct1fl/ mice provide an important tool to examine the
impact of Act1 deficiency in epithelium on the expansion of
Linc-Kit+ cell population in other organs in addition to the gut.Immunity 36, 821–Importantly, we indeed found that the
Linc-Kit+ cells were dramatically
expanded in the lung and liver of wild-
type control mice, but not in that of
epithelial-specific Act1-deficient mice
(Figures 4F, 4G, and S3). These findings
suggest that IL-25 signaling in epithelium
plays a critical role in the expansion of the
Linc-Kit+ cell population in several
organs during worm infection, promoting
type 2 responses and worm expulsion. In
support of this, we found that the
Linc-Kit+ cells sorted from the in-
fected epithelial-specific Act1-deficient
(K18CreAct1fl/) mice were actually as
responsive to IL-25 as those from wild-
type (K18CreAct1fl/+) mice (Figure 4H),
indicating the necessity of IL-25 signalingin epithelium for the initial expansion of the Linc-Kit+ cell popu-
lation during worm infection.
Epithelial Cells Produce IL-25 and IL-33 to Induce the
Expansion of the Lin–c-Kit+ Cell Population
It has been shown that Th2-driving cytokines and Th2-attracting
chemokines (including IL-33, IL-25, TSLP, CCL17, CCL22, and
CCL24) can be produced by epithelial cells, playing an important
role in worm expulsion. We measured their expression in intes-
tinal epithelial cells from the infected K18CreAct1fl/ and
K18CreAct1fl/+ control mice. As shown in Figure 5A, the intestinal
epithelial cells from the infected K18CreAct1fl/ mice had
reduced IL-33, IL-25, TSLP, CCL-17, CCL-22, and CCL-24
expression compared to that from the infected K18CreAct1fl/+
mice. To examine whether IL-25 injection has similar effects on
intestinal epithelial cells, the K18CreAct1fl/ and K18CreAct1fl/+
mice were injected intraperitoneally with IL-25 at day 0 and
day 1. The IECs were isolated from the injected mice at day 2
and analyzed for gene expression by real-time PCR. We found
that the expression of same cytokines and chemokines (IL-33,
IL-25, TSLP, CCL17, CCL22, and CCL24) were reduced in the
IECs from the K18CreAct1fl/ mice compared to that in the
K18CreAct1fl/+ mice (Figure 5B). Taken together, these data
implicate that epithelial-specific Act1 probably contributes to
the IL-25-dependent helminth expulsion through the induction
of Th2-driving cytokines and Th2-attracting chemokines, some833, May 25, 2012 ª2012 Elsevier Inc. 827
Figure 6. Combined Injection of IL-25 and
IL-33 Restored Type 2 Immunity in Epithe-
lial-Specific Act1-Deficient Mice
Wild-type mice were infected with N. brasiliensis;
mice were sacrificed at different time points as
indicated; CD4+ T cells, Linc-Kit+ cells, and
intestinal epithelial cells were isolated; and gene
expression was analyzed by real-time PCR.
(A) IL-25 expression.
(B) IL-33 expression.
(C) Cross-sections of small intestine from naive
C57BL/6 mice were stained with IL-25R anti-
bodies (right); isotype antibody staining was
included as control (left). Green fluorescence
suggests IL-25R positive. Blue shows DAPI
staining.
(D) IL-25R expression (samples from A and B).
(E) ST2 expression (samples from A and B).
(F–I) K18CreAct1fl/ (KO) and K18CreAct1fl/+ (WT)
mice were infected; three groups of KO mice
received IL-25, IL-33, and IL-25+IL-33 injection
(i.p. 500 ng/mouse for 5 days starting from the first
day of infection), respectively. All the mice were
sacrificed 10 days after infection.
(F) Worm burden in small intestine was analyzed.
(G) Serum IgE levels were measured by ELISA.
(H) MLN cells were restimulated by anti-CD3 and
anti-CD28 overnight, followed by IL-13 ELISA in
the collected supernatants.
(I) Absolute numbers of Linc-Kit+ cells in MLN are
shown.
Data represent mean (n = 4) ± SEM; *p < 0.05. The
experiment was repeated two times.
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expansion of the Linc-Kit+ cell population.
To further determine the sources of IL-33 and IL-25 during
worm infection, a kinetic experiment was performed to measure
the induction IL-33 and IL-25 expression in different cells types
after worm infection. We found that the induction of IL-33 and
IL-25 were much earlier and higher in intestinal epithelial cells
as compared to that in CD4+ T cells from MLNs, supporting the
concept that epithelial cells are the initial and main source of
IL-33 and IL-25 afterworm infection (Figures 6Aand6B). Upregu-
lation of IL-33 and IL-25 expression was not observed in
Linc-Kit+ cells. In contrast, the expression kinetics of IL-25Rand
IL-33R (ST2) were distinct from the ligands. Although IL-25R
protein was readily detectable in intestinal epithelial cells, the
induction of IL-33R (ST2) and IL-25R mRNA were much earlier
and higher in Linc-Kit+ cells than that in intestinal epithelial cells
and CD4+ T cells from MLNs (Figures 6C–6E). Taken together,
these results suggest that although epithelial cells are probably
the major sources of IL-25 and IL-33, Linc-Kit+ cells are the key
target cell population of IL-33 and IL-25 during worm infection.828 Immunity 36, 821–833, May 25, 2012 ª2012 Elsevier Inc.Because both IL-33 and IL-25 expres-
sion were much reduced in the IECs
from the infected and IL-25-injected
K18CreAct1fl/ mice compared to that in
the K18CreAct1fl/+ mice, we tested the
ability of these two cytokines to rescue
the type 2 protective immunity againstworm infection in the epithelial-specific Act1-deficient mice.
Importantly, combined injection of IL-25 and IL-33 (but not the
individual cytokines) rescued the type 2 protective immunity
against worm infection in the epithelial-specific Act1-deficient
mice, including reducedworm burdens, enhanced IL-13 produc-
tion, and serum IgE levels (Figures 6F–6H). Furthermore,
injection of IL-33 and IL-25 also restored the Linc-Kit+ cell
population in the epithelial-specific Act1-deficient recipient
mice in response to worm infection (Figure 6I). These results
suggest that the impaired type 2 responses in epithelial-specific
Act1-deficient mice could be, at least partly, due to the reduced
expression of IL-33 and IL-25, which was rescued by the
injection of the exogenous cytokines. It is intriguing that
ex vivo studies showed that IL-25 stimulation can indeed directly
induce the expression of IL-25 and IL-33 in airway and kidney
epithelial cells (data not shown). One exciting possibility is that
epithelial-specific Act1mightmediate IL-25-dependent helminth
expulsion through the positive-feedback loop of IL-25, which
mediates the expansion of the Linc-Kit+ cell population in
conjunction with the production and action of IL-33.
Figure 7. IL-13-Producing Cells Rescued
Type 2 Protective Immunity in Epithelial-
Specific Act1-Deficient Mice
(A) Th2 cells were induced by i.p. injection of
IL-25 consecutively for 7 days at a dose of
1,000 ng/mouse each day. Linc-Kit+ cells were
induced by i.p. injection of IL-25 consecutively for
5 days at a dose of 500 ng/mouse each day. The
frequencies of IL-13-producing CD4+ T cells and
Linc-Kit+ cells are shown.
(B–E) K18CreAct1fl/ (KO) and K18CreAct1fl/+
(WT) mice were infected, and one group of KO
mice received 13 106 Linc-Kit+ cells/mouse and
another group of KO mice received 107 CD4+
T cells/mouse at the same day of infection. All the
mice were sacrificed 10 days after infection.
(B) Worm burden in small intestine was analyzed.
(C) Serum IgE levels were measured by ELISA.
(D) MLN cells were restimulated by anti-CD3 and
anti-CD28 overnight, followed by IL-13 ELISA in
the collected supernatants.
(E) Absolute numbers of Linc-Kit+ cells in MLN
are shown.
Data represent mean (n = 4) ± SEM; *p < 0.05. The
experiment was repeated two times. See also
Figure S4.
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Immunity in Epithelial-Specific Act1-Deficient Mice
Previous studies reported that the innate Linc-Kit+ cell popula-
tion is critical for initiation of type 2 responses and that adoptive
transfer of nuocytes to Il17rb/mice restored protective immu-
nity against worm infection (Neill et al., 2010). We therefore
hypothesized that the reduced expansion of Linc-Kit+ cells in
epithelial-specific Act1-deficient mice might contribute to the
delayed type 2 immunity in these mice. To test this hypothesis,
we isolated Linc-Kit+ cells from MLNs of IL-25-injected mice
and adoptively transferred them to the epithelial-specific Act1-
deficient mice on the same day as worm infection. It is important
to note that about 70% of the Linc-Kit+ cells were IL-13 positive
(Figure 7A). Mice were sacrificed 10 days after infection followed
by analyses for type 2 responses. As shown in Figures 7B–7E,
the transferred Linc-Kit+ cells indeed rescued type 2 protective
immunity in epithelial-specific Act1-deficient mice, including
reduced worm burdens and increased production of IL-13 and
serum IgE.
Although IL-25-induced Act1-mediated signaling in T cells is
dispensable for N. brasiliensis expulsion (Figure S4), CD4+
T cells from MLNs of infected mice were reduced in epithelial-
specific Act1-deficient mice compared to those in wild-type
mice. Therefore, we were interested to examine whether adop-Immunity 36, 821–tive transfer of CD4+ Th2 cells can restore
the protective immunity in the epithelial-
specific Act1-deficient mice. Th2 cells
were induced by i.p. injection of IL-25 in
wild-type mice and characterized by
intracellular staining. CD4+ T cells from
MLNs of IL-25-injected mice (containing
about 20% IL-13-positive cells; Figure 7A)
were isolated and adoptively transferredto the epithelial-specific Act1-deficient mice on the same day
of worm infection. Type 2 responses were assessed 10 days
after infection. As shown in Figures 7B–7D, adoptive transfer of
Th2 cells restored the type 2 responses in epithelial-specific
Act1-deficient recipient mice, including reduced worm burdens
and increased production of IL-13 and serum IgE. It is interesting
to note that adoptive transfer of Th2 cells restored the expansion
of Linc-Kit+ cell population. As shown in Figures 6A and 6B,
IL-33 and IL-25 expression was induced in CD4+ T cells from
MLNs of infected mice, which might help to explain the
ability of IL-25-induced CD4+ Th2 cells in promoting the
expansion of Linc-Kit+ cell population in this adoptive transfer
experiment.
DISCUSSION
In this study, we report that Act1 deficiency in epithelial cells
leads to a significant delay in worm expulsion and decreased
IL-25-induced expansion of the Linc-Kit+ cell population in
the MLN, lung, and liver. IL-25-induced expression of Th2
cell-driving cytokines (including IL-25, IL-33, and TSLP) and
Th2 cell-attracting chemokines (including CCL17, CCL22, and
CCL24) were reduced in the IECs from the IL-25-treated
or infected K18CreAct1fl/ mice compared to that in the833, May 25, 2012 ª2012 Elsevier Inc. 829
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critical for IL-25-dependent helminth expulsion.
The effort to delineate how IL-25 mediates the induction of
type 2 cytokine production during helminth infection has led to
the discovery of a unique cell type mediating antihelminth
responses (Neill et al., 2010; Price et al., 2010; Saenz et al.,
2010a). In our study, we focused on the Linc-Kit+ cell popula-
tion in the MLN during helminth infection, confirming the
absence of defining markers for T cells, B cells, NKT cells,
dendritic cells, macrophages, neutrophils, eosinophils, mast
cells, and basophils. Similar to Ih2, NHC, and nuocytes, we
also detected the expression of the IL-25 receptor (IL-17RA
and IL-17RB) and the IL-33 receptor (T1/ST2) as well as type 2
cytokines (IL-13 and IL-5) in the sorted Linc-Kit+ cell population
from the MLNs of infected or IL-25-injected wild-type mice.
In addition to IL-25, it has been shown that IL-33 can also
induce this Linc-Kit+ cell population. Previous studies have
shown that adoptive transfer of Linc-Kit+ IL-13-producing cells
into N. brasiliensis-infected Il17rb/Il1rl1/ mice (which are
deficient in IL-25 and IL-33 receptor, respectively, and severely
impaired in their ability to expel worms) enabled these animals
to expel the worms (Neill et al., 2010). The fact that Act1 defi-
ciency in epithelial cells diminished the IL-25-induced expansion
of the Linc-Kit+ cell population in the MLN indicates that the
responsiveness of the epithelium to IL-25 is required for the
expansion of this cell population. The expansion of the Linc-Kit+
cell population has been shown to play a critical role in promoting
type 2 responses, so the reduced Linc-Kit+ cell population in
epithelial-specific Act1-deficient mice might account for the
delayed worm expulsion in these mice. Through adoptive
transfer experiment, IL-13-producing Linc-Kit+ cells were
indeed able to rescue type 2 protective immunity in epithelial-
specific Act1-deficient mice, including reduced worm burdens
and increased production of IL-13 and serum IgE, demonstrating
that the Linc-Kit+ cells are the missing link between IL-25-Act1
axis in the epithelium and type 2 responses in epithelial-specific
Act1-deficient mice after worm infection.
IL-33 expression was reduced in the IECs from the IL-25-
treated or infected K18CreAct1fl/ mice compared to that in
the K18CreAct1fl/+ mice, suggesting that epithelial-specific
Act1 might mediate IL-25-dependent helminth expulsion
through the induction of IL-33. In support of this, it was reported
that although IL-25 and IL-33 can lead to the expansion of the
Linc-Kit+ cell population in vivo and render antihelminth immu-
nity through their ability to induce type 2 cytokines, receptor liga-
tion by IL-33 (but not IL-25) facilitates in vitro IL-7-dependent
expansion of the Linc-Kit+ cell population (Neill et al., 2010).
Paradoxically, whereas IL-25 signaling is essential for the expan-
sion of the Linc-Kit+ cell population during infection and is indis-
pensable for worm expulsion, IL-33 signaling is only partially
required. We noted that IL-25 expression was also induced in
the IECs from the IL-25-treated or infected mice, implicating
a possible role of IL-25R signaling in epithelial compartment to
amplify IL-25. Indeed, the induction of IL-25 expression was
diminished in the IECs from K18CreAct1fl/ mice compared to
that in the K18CreAct1fl/+ mice, suggesting that epithelial-
specific Act1 might also mediate IL-25-dependent helminth
expulsion through the positive-feedback loop of IL-25. Of note,
combined treatment of IL-25 and IL-33 (but not individual cyto-830 Immunity 36, 821–833, May 25, 2012 ª2012 Elsevier Inc.kine) rescued the type 2 protective immunity against worm infec-
tion in the epithelial-specific Act1-deficient mice, including
reduced worm burdens, and restored the Linc-Kit+ cell popula-
tion. These results suggest that epithelial-specific Act1 might
mediate IL-25-dependent helminth expulsion through the posi-
tive-feedback loop of IL-25, which mediates the expansion of
Linc-Kit+ cell population in conjunction with the production
and action of IL-33.
These findings are consistent with the previous reports that
the mucosal epithelium plays a critical role in the mounting of
type 2 responses and is central to the pathogenesis of allergic
inflammation through the production of a wide range of cyto-
kines, chemokines, and growth factors (Holgate, 2007a,
2007b, 2008; Kato and Schleimer, 2007; Schleimer et al.,
2007). IL-25 expression is induced in lung epithelial cells in
response to allergens. IL-25 stimulation of airway epithelial cells
induced the expression of type 2 cytokines (IL-33, IL-25, and
TSLP) and Th2 cell-attracting chemokines (CCL17, CCL22,
and CCL24). In this study, we confirm that whereas epithelial
cells are the major source of IL-25 and IL-33, Linc-Kit+ cells
are the key target cell population of IL-33 and IL-25 during
worm infection. Moreover, the Linc-Kit+ cells were also dramat-
ically expanded in the lung and liver of wild-type control mice,
but not in that of epithelial-specific Act1-deficient mice. These
findings suggest that IL-25 signaling in epithelium plays a critical
role in the expansion of the Linc-Kit+ cell population in several
organs during worm infection, promoting type 2 responses and
worm expulsion. These findings indicate that epithelium initiates
type 2 responses by producing IL-25 and responding to it.
In addition to IL-25 and IL-33, IL-25-induced expression of
TSLP and Th2 cell-attracting chemokines were also reduced in
the IECs from the K18CreAct1fl/ mice compared to that in the
K18CreAct1fl/+ mice. Consistently, the expression of TSLP,
CCL17, CCL22, and CCL24 were reduced in the IECs from the
infected K18CreAct1fl/ mice compared to that in the
K18CreAct1fl/+ mice. It is important to note that whereas Act1
deficiency in epithelium greatly diminished the Linc-Kit+ cells
but not the CD4+ Th2 cell population 5 days after infection, the
IL-13-producing MLN CD4+ Th2 cell population was expanded
10 days after infection, which was partially dependent on the
epithelial-specific Act1. Future studies are required to determine
whether IL-25-induced expression of TSLP and chemokines in
IECs might contribute to the expansion of the CD4+ Th2 cell
population during worm infection. The IL-4- and IL-13-reporter
mice has allowed more detailed studies of the dynamic and
kinetic localization of IL-13-producing Linc-Kit+ and CD4+ Th2
cells in vivo during worm infection (Liang et al., 2012; Neill
et al., 2010; Price et al., 2010; Saenz et al., 2010b). It will be
important to further investigate how the Linc-Kit+ and CD4+
Th2 cells coordinately initiate, amplify, and sustain Th2 cell
protective immunity.
EXPERIMENTAL PROCEDURES
Mice and Helminth Infection
Act1-deficient C57BL/6 mice and K18 Cre transgenic mice were generated as
described previously (Qian et al., 2004; Wen et al., 2003). C57BL/6J and
B6.Cg-Tg (Lck-cre) mice were purchased from Jackson laboratory. CD11bCre
transgenic mice were provided by G. Kollias (Biomedical Sciences Research
Centre ‘‘Alexander Fleming’’) (Boille´e et al., 2006). CD11bCre-mediated and
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described previously (Kang et al., 2010; Swaidani et al., 2009). IL-17-deficient
mice were provided by Y. Iwakura (Nakae et al., 2002). Individual mice were
inoculated subcutaneously with 500 viable third-stage N. brasiliensis larvae.
Animals were sacrificed 5, 10, and 15 days after infection. The intestinal
worm burdens were determined, and serum was taken. All mice used in the
experiment were housed under specific-pathogen-free conditions. Experi-
mental protocols were approved by the Institutional Animal Care and Use
Committee of Cleveland Clinic.
Culture of Bone-Marrow-Derived Macrophages
Bone marrow cell suspensions were prepared from one femur and then ACK
lysed. A total number of 5 3 106 cells/ml was cultured with 30 ng/ml M-CSF
for 5 days. Then cells were harvested and incubated in fresh medium with
100 ng/ml IL-25, 10 ng/ml IL-4, or a combination of IL-25+IL-4 for 24 hr. Cells
incubated without cytokines were included as control. Then, RNAwas isolated
and assayed by real-time PCR.
Isolation of Intestinal Epithelial Cells
Intestinal epithelial cells were isolated by using a modification of the methods
described previously (Whitehead et al., 1999; Evans et al., 1992, 1994). Intes-
tines were cut into 2–3 mm fragments and washed by PBS five times with
vigorous shaking. Then, intestines were incubated with 3 mM EDTA and
0.5 mM dithiothreitol at room temperature for 30 min with shaking. Crypts
released from the intestine by shaking were washed with PBS and solubilized
by cell lysis buffer. To test the contamination of leukocytes, crypts were
digested by collagenase I and dispase I, and single cells were stained by
CD45 antibodies. Less than 2% of CD45-positive cells were detected,
suggesting high purity of collected IECs.
Isolation Lung and Liver Mononuclear Cells for Flow Cytometry
Lung and liver tissues were cut into small pieces and digested with collage-
nase D (Sigma). Then, the tissues were filtered through a cell strainer. For
lung MNCs, red cells were lysed and ready for flow cytometry. For liver,
30% percol were used to isolate the MNCs and red cells were lysed before
flow cytometry. CD45 antibodies were used for gating on leukocytes.
T Cell Restimulation
Mice were sacrificed at different time points after infection. Mesenteric lymph
nodes were collected. T cells were restimulated by coated CD3+CD28
antibodies (eBioscience) overnight. Supernatants were harvested for ELISA
assays.
Bronchoalveolar Lavage and Tissue Collection
Mice were sacrificed at the times indicated. A total of 0.7 ml of HL-1 medium
(BioWhittaker) was used to obtain BAL fluid through trachea by means of
a blunt needle and 1 ml syringe. Total cells were counted manually and cell
subsets were analyzed by flow cytometry. Macrophages were characterized
by F4/80 antibody (Serotech) and granulocytes by Gr-1 antibody (BD Biosci-
ences). Flow cytometry of stained cells was performed with a FACSCalibur
(BD Biosciences). Data were analyzed with FlowJo software (Tree Star). Lungs
and mesenteric lymph nodes were collected and snap frozen immediately in
liquid nitrogen container for RNA extraction.
Flow Cytometry and Cell Sorting
Fluorescence-conjugated CD3, CD4, CD8, TCR-b, TCR-gd, B220, CD19,
NK1.1, Ter119, Gr-1, CD11b, CD11c, FcεRI, c-Kit antibodies, and isotype
controls were all purchased from BD Biosciences. For cell surface staining,
cells were blocked with 1% BSA plus 2 mg/ml CD16/32 FcR blocker
(BD Biosciences) for 30 min on ice. Then, cells were incubated with antibodies
for 30 min on ice. Cells were then washed three times and fixed by 1% para-
formaldehyde. Data were analyzed by FlowJo software (Tree Star). For sorting
of Linc-Kit+ cells, MLN cells from wild-type mice 5 days after worm infection
were collected, and Linc-Kit+ cells were enriched by negative deletion of
lineage-positive cells (CD3, CD4, CD8, TCR-b, TCR-gd, B220, CD19, NK1.1,
Ter119, Gr-1, CD11b, CD11c, and FcεRI) by MACS. Then, Linc-Kit+ cells
were sorted by FACS. Portion of isolated cells were stained with lineage
markers to check the purity, and the cell purity was higher than 99%.ELISA
IgE, IL-4, and IL-13 level were assayed by mouse IgE ELISA Set (BD Biosci-
ences) and murine IL-4 and IL-13 Quantikine ELISA Kit (R&D systems). All
procedures followed the manufacturer’s instructions.
Real-Time PCR
Total RNA was extracted from lungs and lymph nodes with TRIzol (Invitrogen)
according to the manufacturer’s instructions. All gene expression results are
expressed as arbitrary units relative to expression of the gene encoding
b-actin. The specific primer sequences used in reaction are listed in Table S1.
Statistical Analysis
The significance of differences between two groups was determined by
Student’s t test (two-tailed). Unless otherwise specified, all results are shown
as mean and the standard error of the mean (mean ± SEM). A p value of <0.05
was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and one table and can be
found with this article online at doi:10.1016/j.immuni.2012.03.021.
ACKNOWLEDGMENTS
We gratefully acknowledge G. Kollias for provision of CD11bCre transgenic
mice. This investigation was supported by National Institutes of Health grants
RO1HL098935-01A1 (X.L.) and AI080908 (B.M.) and Sandler award for asthma
09-0035 (X.L.).
Received: July 7, 2011
Revised: January 18, 2012
Accepted: March 8, 2012
Published online: May 17, 2012
REFERENCES
Angkasekwinai, P., Park, H., Wang, Y.H., Wang, Y.H., Chang, S.H., Corry,
D.B., Liu, Y.J., Zhu, Z., and Dong, C. (2007). Interleukin 25 promotes the
initiation of proallergic type 2 responses. J. Exp. Med. 204, 1509–1517.
Anthony, R.M., Rutitzky, L.I., Urban, J.F., Jr., Stadecker, M.J., and Gause,
W.C. (2007). Protective immune mechanisms in helminth infection. Nat. Rev.
Immunol. 7, 975–987.
Artis, D. (2008). Epithelial-cell recognition of commensal bacteria and mainte-
nance of immune homeostasis in the gut. Nat. Rev. Immunol. 8, 411–420.
Boille´e, S., Yamanaka, K., Lobsiger, C.S., Copeland, N.G., Jenkins, N.A.,
Kassiotis, G., Kollias, G., and Cleveland, D.W. (2006). Onset and progression
in inherited ALS determined by motor neurons and microglia. Science 312,
1389–1392.
Chang, S.H., and Dong, C. (2011). Signaling of interleukin-17 family cytokines
in immunity and inflammation. Cell. Signal. 23, 1069–1075.
Claudio, E., Sønder, S.U., Saret, S., Carvalho, G., Ramalingam, T.R., Wynn,
T.A., Chariot, A., Garcia-Perganeda, A., Leonardi, A., Paun, A., et al. (2009).
The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway
inflammation. J. Immunol. 182, 1617–1630.
Day, K.P., Howard, R.J., Prowse, S.J., Chapman, C.B., and Mitchell, G.F.
(1979). Studies on chronic versus transient intestinal nematode infections in
mice. I. A. comparison of responses to excretory/secretory (ES) products of
Nippostrongylus brasiliensis and Nematospiroides dubius worms. Parasite
Immunol. 1, 217–239.
Evans, G.S., Flint, N., Somers, A.S., Eyden, B., and Potten, C.S. (1992). The
development of a method for the preparation of rat intestinal epithelial cell
primary cultures. J. Cell Sci. 101, 219–231.
Evans, G.S., Flint, N., and Potten, C.S. (1994). Primary cultures for studies of
cell regulation and physiology in intestinal epithelium. Annu. Rev. Physiol.
56, 399–417.Immunity 36, 821–833, May 25, 2012 ª2012 Elsevier Inc. 831
Immunity
IL-25-Act1 Axis Is Critical for Helminth ImmunityFallon, P.G., Ballantyne, S.J., Mangan, N.E., Barlow, J.L., Dasvarma, A.,
Hewett, D.R., McIlgorm, A., Jolin, H.E., and McKenzie, A.N. (2006).
Identification of an interleukin (IL)-25-dependent cell population that provides
IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 203,
1105–1116.
Fort, M.M., Cheung, J., Yen, D., Li, J., Zurawski, S.M., Lo, S., Menon, S.,
Clifford, T., Hunte, B., Lesley, R., et al. (2001). IL-25 induces IL-4, IL-5, and
IL-13 and Th2-associated pathologies in vivo. Immunity 15, 985–995.
Gaffen, S.L. (2009). Structure and signalling in the IL-17 receptor family. Nat.
Rev. Immunol. 9, 556–567.
Gregory, L.G., Mathie, S.A., Walker, S.A., Pegorier, S., Jones, C.P., and Lloyd,
C.M. (2010). Overexpression of Smad2 drives house dust mite-mediated
airway remodeling and airway hyperresponsiveness via activin and IL-25.
Am. J. Respir. Crit. Care Med. 182, 143–154.
Herbert, D.R., Yang, J.Q., Hogan, S.P., Groschwitz, K., Khodoun, M., Munitz,
A., Orekov, T., Perkins, C., Wang, Q., Brombacher, F., et al. (2009). Intestinal
epithelial cell secretion of RELM-beta protects against gastrointestinal worm
infection. J. Exp. Med. 206, 2947–2957.
Ho, A.W., and Gaffen, S.L. (2010). IL-17RC: a partner in IL-17 signaling and
beyond. Semin. Immunopathol. 32, 33–42.
Holgate, S.T. (2007a). Epithelium dysfunction in asthma. J. Allergy Clin.
Immunol. 120, 1233–1244, quiz 1245–1246.
Holgate, S.T. (2007b). The epithelium takes centre stage in asthma and atopic
dermatitis. Trends Immunol. 28, 248–251.
Holgate, S.T. (2008). The airway epithelium is central to the pathogenesis of
asthma. Allergol. Int. 57, 1–10.
Iwakura, Y., Ishigame, H., Saijo, S., and Nakae, S. (2011). Functional special-
ization of interleukin-17 family members. Immunity 34, 149–162.
Kang, Z., Altuntas, C.Z., Gulen, M.F., Liu, C., Giltiay, N., Qin, H., Liu, L., Qian,
W., Ransohoff, R.M., Bergmann, C., et al. (2010). Astrocyte-restricted ablation
of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune
encephalomyelitis. Immunity 32, 414–425.
Kato, A., and Schleimer, R.P. (2007). Beyond inflammation: airway epithelial
cells are at the interface of innate and adaptive immunity. Curr. Opin.
Immunol. 19, 711–720.
Katona, I.M., Urban, J.F., Jr., and Finkelman, F.D. (1988). The role of L3T4+
and Lyt-2+ T cells in the IgE response and immunity to Nippostrongylus brasi-
liensis. J. Immunol. 140, 3206–3211.
Kreider, T., Anthony, R.M., Urban, J.F., Jr., and Gause, W.C. (2007).
Alternatively activated macrophages in helminth infections. Curr. Opin.
Immunol. 19, 448–453.
Li, X. (2008). Act1 modulates autoimmunity through its dual functions in
CD40L/BAFF and IL-17 signaling. Cytokine 41, 105–113.
Liang, H.E., Reinhardt, R.L., Bando, J.K., Sullivan, B.M., Ho, I.C., and
Locksley, R.M. (2012). Divergent expression patterns of IL-4 and IL-13 define
unique functions in allergic immunity. Nat. Immunol. 13, 58–66.
Liu, C., Qian,W., Qian, Y., Giltiay, N.V., Lu, Y., Swaidani, S., Misra, S., Deng, L.,
Chen, Z.J., and Li, X. (2009). Act1, a U-box E3 ubiquitin ligase for IL-17
signaling. Sci. Signal. 2, ra63.
Martinez, F.O., Helming, L., and Gordon, S. (2009). Alternative activation of
macrophages: an immunologic functional perspective. Annu. Rev. Immunol.
27, 451–483.
Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H.,
Furusawa, J., Ohtani, M., Fujii, H., and Koyasu, S. (2010). Innate production
of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid
cells. Nature 463, 540–544.
Nakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I.,
Sekikawa, K., Asano, M., and Iwakura, Y. (2002). Antigen-specific T cell sensi-
tization is impaired in IL-17-deficient mice, causing suppression of allergic
cellular and humoral responses. Immunity 17, 375–387.
Neill, D.R., and McKenzie, A.N. (2011). Nuocytes and beyond: new insights
into helminth expulsion. Trends Parasitol. 27, 214–221.832 Immunity 36, 821–833, May 25, 2012 ª2012 Elsevier Inc.Neill, D.R., Wong, S.H., Bellosi, A., Flynn, R.J., Daly, M., Langford, T.K., Bucks,
C., Kane, C.M., Fallon, P.G., Pannell, R., et al. (2010). Nuocytes represent
a new innate effector leukocyte that mediates type-2 immunity. Nature 464,
1367–1370.
Novatchkova, M., Leibbrandt, A., Werzowa, J., Neubu¨ser, A., and Eisenhaber,
F. (2003). The STIR-domain superfamily in signal transduction, development
and immunity. Trends Biochem. Sci. 28, 226–229.
Owyang, A.M., Zaph, C., Wilson, E.H., Guild, K.J., McClanahan, T., Miller,
H.R., Cua, D.J., Goldschmidt, M., Hunter, C.A., Kastelein, R.A., and Artis, D.
(2006). Interleukin 25 regulates type 2 cytokine-dependent immunity and
limits chronic inflammation in the gastrointestinal tract. J. Exp. Med. 203,
843–849.
Pan, G., French, D., Mao, W., Maruoka, M., Risser, P., Lee, J., Foster, J.,
Aggarwal, S., Nicholes, K., Guillet, S., et al. (2001). Forced expression of
murine IL-17E induces growth retardation, jaundice, a Th2-biased response,
and multiorgan inflammation in mice. J. Immunol. 167, 6559–6567.
Paul, W.E., and Zhu, J. (2010). How are T(H)2-type immune responses initiated
and amplified? Nat. Rev. Immunol. 10, 225–235.
Price, A.E., Liang, H.E., Sullivan, B.M., Reinhardt, R.L., Eisley, C.J., Erle, D.J.,
and Locksley, R.M. (2010). Systemically dispersed innate IL-13-expressing
cells in type 2 immunity. Proc. Natl. Acad. Sci. USA 107, 11489–11494.
Qian, Y., Qin, J., Cui, G., Naramura, M., Snow, E.C., Ware, C.F., Fairchild, R.L.,
Omori, S.A., Rickert, R.C., Scott, M., et al. (2004). Act1, a negative regulator in
CD40- and BAFF-mediated B cell survival. Immunity 21, 575–587.
Qian, Y., Liu, C., Hartupee, J., Altuntas, C.Z., Gulen, M.F., Jane-Wit, D., Xiao,
J., Lu, Y., Giltiay, N., Liu, J., et al. (2007). The adaptor Act1 is required for
interleukin 17-dependent signaling associated with autoimmune and inflam-
matory disease. Nat. Immunol. 8, 247–256.
Saenz, S.A., Taylor, B.C., and Artis, D. (2008). Welcome to the neighborhood:
epithelial cell-derived cytokines license innate and adaptive immune
responses at mucosal sites. Immunol. Rev. 226, 172–190.
Saenz, S.A., Noti, M., and Artis, D. (2010a). Innate immune cell populations
function as initiators and effectors in Th2 cytokine responses. Trends
Immunol. 31, 407–413.
Saenz, S.A., Siracusa, M.C., Perrigoue, J.G., Spencer, S.P., Urban, J.F., Jr.,
Tocker, J.E., Budelsky, A.L., Kleinschek, M.A., Kastelein, R.A., Kambayashi,
T., et al. (2010b). IL25 elicits a multipotent progenitor cell population that
promotes T(H)2 cytokine responses. Nature 464, 1362–1366.
Schleimer, R.P., Kato, A., Kern, R., Kuperman, D., and Avila, P.C. (2007).
Epithelium: at the interface of innate and adaptive immune responses.
J. Allergy Clin. Immunol. 120, 1279–1284.
Siracusa, M.C., Reece, J.J., Urban, J.F., Jr., and Scott, A.L. (2008). Dynamics
of lung macrophage activation in response to helminth infection. J. Leukoc.
Biol. 84, 1422–1433.
Strickland, D.H., Upham, J.W., and Holt, P.G. (2010). Epithelial-dendritic cell
interactions in allergic disorders. Curr. Opin. Immunol. 22, 789–794.
Swaidani, S., Bulek, K., Kang, Z., Liu, C., Lu, Y., Yin, W., Aronica, M., and Li, X.
(2009). The critical role of epithelial-derived Act1 in IL-17- and IL-25-mediated
pulmonary inflammation. J. Immunol. 182, 1631–1640.
Swaidani, S., Bulek, K., Kang, Z., Gulen, M.F., Liu, C., Yin, W., Abbadi, A.,
Aronica, M., and Li, X. (2011). T cell-derived Act1 is necessary for IL-25-
mediated Th2 responses and allergic airway inflammation. J. Immunol. 187,
3155–3164.
Toy, D., Kugler, D., Wolfson, M., Vanden Bos, T., Gurgel, J., Derry, J., Tocker,
J., and Peschon, J. (2006). Cutting edge: interleukin 17 signals through
a heteromeric receptor complex. J. Immunol. 177, 36–39.
Trajkovic, V., Stosic-Grujicic, S., Samardzic, T., Markovic, M., Miljkovic, D.,
Ramic, Z., andMostarica Stojkovic, M. (2001). Interleukin-17 stimulates induc-
ible nitric oxide synthase activation in rodent astrocytes. J. Neuroimmunol.
119, 183–191.
Voehringer, D., Reese, T.A., Huang, X., Shinkai, K., and Locksley, R.M. (2006).
Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-
eosinophil cells of the innate immune system. J. Exp. Med. 203, 1435–1446.
Immunity
IL-25-Act1 Axis Is Critical for Helminth ImmunityWang, Y.H., Angkasekwinai, P., Lu, N., Voo, K.S., Arima, K., Hanabuchi, S.,
Hippe, A., Corrigan, C.J., Dong, C., Homey, B., et al. (2007). IL-25 augments
type 2 immune responses by enhancing the expansion and functions of
TSLP-DC-activated Th2 memory cells. J. Exp. Med. 204, 1837–1847.
Wen, F., Cecena, G., Munoz-Ritchie, V., Fuchs, E., Chambon, P., and Oshima,
R.G. (2003). Expression of conditional cre recombinase in epithelial tissues of
transgenic mice. Genesis 35, 100–106.
Whitehead, R.H., Demmler, K., Rockman, S.P., and Watson, N.K. (1999).
Clonogenic growth of epithelial cells from normal colonic mucosa from both
mice and humans. Gastroenterology 117, 858–865.
Zaph, C., Troy, A.E., Taylor, B.C., Berman-Booty, L.D., Guild, K.J., Du, Y.,
Yost, E.A., Gruber, A.D., May, M.J., Greten, F.R., et al. (2007). Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis.
Nature 446, 552–556.
Zaph, C., Du, Y., Saenz, S.A., Nair, M.G., Perrigoue, J.G., Taylor, B.C., Troy,
A.E., Kobuley, D.E., Kastelein, R.A., Cua, D.J., et al. (2008). Commensal-
dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine.
J. Exp. Med. 205, 2191–2198.
Zhao, A., Urban, J.F., Jr., Sun, R., Stiltz, J., Morimoto, M., Notari, L., Madden,
K.B., Yang, Z., Grinchuk, V., Ramalingam, T.R., et al. (2010). Critical role of
IL-25 in nematode infection-induced alterations in intestinal function.
J. Immunol. 185, 6921–6929.Immunity 36, 821–833, May 25, 2012 ª2012 Elsevier Inc. 833
